ESC 2015 Schedule: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(20 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
÷
Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.
Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.


Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom
Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom
----
__NOTOC__


== Click on Date for Detailed Schedule ==
== Click on Date for Detailed Schedule ==


== Monday, March 16, 2015 ==
[[{{PAGENAME}}#Sunday, August 30, 2015| Sunday, August 30, 2015]]
 
[[{{PAGENAME}}#Monday, August 31, 2015| Monday, August 31, 2015]]
 
[[{{PAGENAME}}#Tuesday, September 1, 2015| Tuesday, September 1, 2015]]
 
[[{{PAGENAME}}#Wednesday, September 2, 2015| Wednesday, September 2, 2015]]
 
----
== Sunday, August 30, 2015 ==
 
=== 4:30 PM ===
* '''Interviewee:''' Dr. Robert Byrne
* '''Topic:''' ESC 2015 Wrap-Up from the Perspective of the UK/Ireland
 
== Monday, August 31, 2015 ==


=== 8:00 AM ===
=== 8:00 AM ===
''OPEN TIME SLOT''
<font color=red>OPEN TIME SLOT</font>


=== 8:30 AM ===
=== 8:30 AM ===
* '''Interviewee:'''Dr. Vivek Reddy
* '''Interviewee:''' Dr. Vivek Reddy
* '''Topic:'''Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
* '''Topic:''' Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
* '''Embargo Lift:''' Sunday, August 30th at 5:38 PM
* '''Embargo Lift:''' Sunday, August 30th at 5:38 PM


=== 9:00 AM ===
=== 9:00 AM ===
''OPEN TIME SLOT''
<font color=red>OPEN TIME SLOT</font>


=== 9:30 AM ===
=== 9:30 AM ===
* '''Interviewee: '''Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
* '''Interviewee: ''' Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
* '''Topic: '''Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial '''AND '''Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
* '''Topic: ''' Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial '''AND '''Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
* '''Embargo Lift:''' Sunday, August 30th at 4:30 PM''' and''' Sunday, august 30th at 4:30 PM
* '''Embargo Lift:''' Sunday, August 30th at 4:30 PM''' and''' Sunday, August 30th at 4:30 PM


=== 10:00 AM ===
=== 10:00 AM ===
* '''Interviewee:'''Pr. Michel Ovize
* '''Interviewee:''' Pr. Michel Ovize
* '''Topic:'''Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
* '''Topic:''' Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
* '''Embargo Lift: '''Sunday, August 30th, at 12:27 PM
* '''Embargo Lift: '''Sunday, August 30th, at 12:27 PM


=== 10:30 AM ''(PENDING)'' ===
=== 10:30 AM ===
* '''Interviewee:'''Dr. Luigi Di Biase
<font color=red>OPEN TIME SLOT</font>
* '''Topic:'''Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
* '''Embargo Lift:'''Sunday March 15, 2015 at 9:00AM
 
=== 11:00 AM ===
* '''Interviewee:'''Dr. Marc Gillinov
* '''Topic:'''Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network
* '''Embargo Lift:'''Monday March 16, 2015 at 8:15AM


=== 11:30 AM ===
=== 11:30 AM ===
* '''Interviewee:'''Dr. Rajeev K. Pathak
* '''Interviewee:''' Dr. Morris Brown
* '''Topic:'''Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
* '''Topic:''' Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
* '''Embargo Lift:'''Monday March 16, 2015 at 8:30AM
* '''Embargo Lift:''' Monday August 31st at 5:16 PM


=== 12:00 PM ===
=== 12:00 PM ===
* '''Interviewee:''' Dr. Luigi Di Biase
* '''Topic:''' Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF     
* '''Embargo Lift:''' Sunday, August 30th at 4:53 PM


=== 12:30 PM ===
=== 12:30 PM ===
* '''Interviewee:'''Dr. Rino Sardella
<font color=red>OPEN TIME SLOT</font>
* '''Topic:'''ACC 2015 Wrap-Up in Italian


=== 1:00 PM ===
=== 1:00 PM ===
* '''Interviewee:'''Dr. Hisao Ogawa
<font color=red>OPEN TIME SLOT</font>
* '''Topic:'''ACC 2015 Wrap-Up in Japanese


=== 1:30 PM ===
=== 1:30 PM ===
* '''Interviewee:'''Dr. Susheel Kodali
* '''Interviewee:''' Dr. Eldrin Lewis
* '''Topic:'''Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients
* '''Topic:''' The evaluation of Lixisenatide in acute coronary syndromes (ELIXA).
* '''Embargo Lift:'''Sunday March 15, 2015 at 11:15AM
* '''Embargo Lift:''' Monday, August 31st at 11:36 AM


=== 2:00 PM ===
=== 2:00 PM ===
<font color=red>OPEN TIME SLOT</font>


=== 2:30 PM ===
=== 2:30 PM ===
* '''Interviewee:'''Dr. Pamela S. Douglas
* '''Interviewee:''' Dr. Dirk Westermann
* '''Topic:'''A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
* '''Topic: '''Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
* '''Embargo Lift:'''Saturday March 14, 2015 at 9:05AM
* '''Embargo Lift:''' Sunday, August 30th at 11:00 AM


=== 3:00 PM ===
=== 3:00 PM ===
* '''Interviewee:'''Dr. Marco Valgimigli
* '''Interviewee:''' Dr. Basil Lewis
* '''Topic:'''Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program'''&'''Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
* '''Topic: '''ESC 2015 Wrap-up in Hebrew
* '''Embargo Lift:'''Monday March 16, 2015 at 11:00AM'''&'''Monday March 16, 2015 at 11:15AM, respectively


=== 3:30 PM ===
=== 3:30 PM ===
* '''Interviewee:'''Dr. Marc Steven Sabatine
* '''Interviewee:''' Dr. Renato Lopes
* '''Topic:'''Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
* '''Topic:''' ESC 2015 Wrap-up in Portuguese
* '''Embargo Lift:'''Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively


=== 4:00 PM ===
=== 4:00 PM ===
* '''Interviewee:'''Dr. Roxana Mehran
* '''Interviewee:''' Pr. Freek Verheugt
* '''Topic:'''A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
* '''Topic: '''ESC 2015 Wrap-up from the Perspective of the Netherlands
* '''Embargo Lift:'''Sunday March 15, 2015 at 8:30AM


=== 4:30 PM ===
=== 4:30 PM ===
* '''Interviewee:'''Dr. Thomas Engstrøm
<font color=red>OPEN TIME SLOT</font>
* '''Topic:'''The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
* '''Embargo Lift:'''Monday March 16, 2015 at 11:30AM


=== 5:00 PM ===
== Tuesday, September 1, 2015 ==
* '''Interviewee:'''Prof. Dr. Sigmund Silber
* '''Topic:'''ACC 2015 Wrap-Up in German
 
== Tuesday, March 17, 2015 ==


=== 8:00 AM ===
=== 8:00 AM ===
<font color=red>OPEN TIME SLOT</font>


=== 8:30 AM ===
=== 8:30 AM ===
<font color=red>OPEN TIME SLOT</font>


=== 9:00 AM ===
=== 9:00 AM ===
<font color=red>OPEN TIME SLOT</font>


=== 9:30 AM ===
=== 9:30 AM ===
* '''Interviewee: ''' Dr. Takeshi Kimura
* '''Topic: '''ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
* '''Embrago Lift: '''Tuesday, September 1st at 5:06 PM


=== 10:00 AM ===
=== 10:00 AM ===
* '''Interviewee:''' Dr. Gérard Helft
* '''Topic: '''The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
* '''Embargo Lift: '''Monday, August 31st at 12:12 PM


=== 10:30 AM ===
=== 10:30 AM ===
* '''Interviewee:''' Dr. Pamela Douglas
* '''Topic:''' Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
* '''Embargo Lift:''' Tuesday, September 1st at 4:30 PM


=== 11:00 AM ===
=== 11:00 AM ===
* '''Interviewee:''' Dr. Hisao Ogawa
* '''Topic: '''A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients '''AND '''ESC 2015 Wrap-up in''' '''Japanese
* '''Embargo Lift:''' Monday August 31st at 4:30 PM


=== 11:30 AM ===
=== 11:30 AM ===
* '''Interviewee:''' Dr. Marco Valgimigli
* '''Topic: '''Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX (MATRIX Antithrombin)
* '''Embargo Lift:''' Tuesday, September 1st at 5:24 PM


=== 12:00 PM ===
=== 12:00 PM ===
* '''Interviewee:''' Pr. Thomas MacDonald
* '''Topic: '''The Standard care versus Celecoxib Outcome Trial (SCOT); a randomised, trial comparing the cardiovascular safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs.
* '''Embargo Lift:''' Monday, August 31st at 11:54 AM


=== 12:30 PM ===
=== 12:30 PM ===
<font color=red>OPEN TIME SLOT</font>


=== 1:00 PM ===
=== 1:00 PM ===
* '''Interviewee:''' Dr. Gregg Stone
* '''Topic:''' Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
* '''Embargo Lift: '''Sunday, August 30th at 11:54 AM


=== 1:30 PM ===
=== 1:30 PM ===
* '''Interviewee:''' Dr. Patrick Serruys
* '''Topic: '''Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
* '''Embargo Lift: '''Tuesday, September 1st at 4:48 PM


=== 2:00 PM ===
=== 2:00 PM ===
 
* '''Interviewee: ''' Dr. Frank Rademakers
=== 2:30 PM ===
* '''Topic: '''Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients
* '''Embrago Lift: '''Sunday, August 30th at 11:18 AM


=== 3:00 PM ===
=== 3:00 PM ===
* '''Interviewee: '''Dr. Gerasimos Filippatos
* '''Topic:''' Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
* '''Embargo Lift:''' Monday, August 31st at 11:18 AM


=== 3:30 PM ===
=== 3:30 PM ===
* '''Interviewee:''' Dr. Carlos A. Morillo
* '''Topic: '''The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
* '''Embargo Lift:''' Tuesday, September 1st at 12:08 PM


=== 4:00 PM ===
=== 4:00 PM ===
* '''Interviewee: '''Dr. Stefan James (and guest Dr. Jonas Oldgren)
* '''Topic: '''Wrap-up from a Scandinavian Perspective


=== 4:30 PM ===
=== 4:30 PM ===
* '''Interviewee: ''' Dr. Sergio Leonardi (and guest Pr. Gaetano De Ferrari)
* '''Topic: '''ESC 2015 Wrap-Up in Italian
=== 5:00 PM - 6:00 PM ===
* Interviewee: Pr. Gilles Montalescot
* Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial '''AND''' Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study '''AND''' ESC 2015 Wrap-up in''' '''French
* Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) '''and '''Sunday, August 30th at 5:16 PM (AEGEAN)
== Wednesday, September 2, 2015 ==
=== 8:00 AM ===
<font color=red>OPEN TIME SLOT</font>
=== 8:30 AM ===
<font color=red>OPEN TIME SLOT</font>
=== 9:00 AM ===
* '''Interviewee: ''' Pr. Harvey White
* '''Topic: ''' ESC 2015 Wrap-Up from Perspective from the Pacific Rim
=== 9:30 AM ===
* '''Interviewee: ''' Pr. Sigmund Silber
* '''Topic: '''        ESC 2015 Wrap-Up in German

Latest revision as of 14:42, 12 August 2015

÷ Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.

Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom


Click on Date for Detailed Schedule

Sunday, August 30, 2015

Monday, August 31, 2015

Tuesday, September 1, 2015

Wednesday, September 2, 2015

Sunday, August 30, 2015

4:30 PM

  • Interviewee: Dr. Robert Byrne
  • Topic: ESC 2015 Wrap-Up from the Perspective of the UK/Ireland

Monday, August 31, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

  • Interviewee: Dr. Vivek Reddy
  • Topic: Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
  • Embargo Lift: Sunday, August 30th at 5:38 PM

9:00 AM

OPEN TIME SLOT

9:30 AM

  • Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
  • Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
  • Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, August 30th at 4:30 PM

10:00 AM

  • Interviewee: Pr. Michel Ovize
  • Topic: Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
  • Embargo Lift: Sunday, August 30th, at 12:27 PM

10:30 AM

OPEN TIME SLOT

11:30 AM

  • Interviewee: Dr. Morris Brown
  • Topic: Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
  • Embargo Lift: Monday August 31st at 5:16 PM

12:00 PM

  • Interviewee: Dr. Luigi Di Biase
  • Topic: Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF
  • Embargo Lift: Sunday, August 30th at 4:53 PM

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

  • Interviewee: Dr. Eldrin Lewis
  • Topic: The evaluation of Lixisenatide in acute coronary syndromes (ELIXA).
  • Embargo Lift: Monday, August 31st at 11:36 AM

2:00 PM

OPEN TIME SLOT

2:30 PM

  • Interviewee: Dr. Dirk Westermann
  • Topic: Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
  • Embargo Lift: Sunday, August 30th at 11:00 AM

3:00 PM

  • Interviewee: Dr. Basil Lewis
  • Topic: ESC 2015 Wrap-up in Hebrew

3:30 PM

  • Interviewee: Dr. Renato Lopes
  • Topic: ESC 2015 Wrap-up in Portuguese

4:00 PM

  • Interviewee: Pr. Freek Verheugt
  • Topic: ESC 2015 Wrap-up from the Perspective of the Netherlands

4:30 PM

OPEN TIME SLOT

Tuesday, September 1, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

  • Interviewee: Dr. Takeshi Kimura
  • Topic: ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
  • Embrago Lift: Tuesday, September 1st at 5:06 PM

10:00 AM

  • Interviewee: Dr. Gérard Helft
  • Topic: The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
  • Embargo Lift: Monday, August 31st at 12:12 PM

10:30 AM

  • Interviewee: Dr. Pamela Douglas
  • Topic: Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
  • Embargo Lift: Tuesday, September 1st at 4:30 PM

11:00 AM

  • Interviewee: Dr. Hisao Ogawa
  • Topic: A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients AND ESC 2015 Wrap-up in Japanese
  • Embargo Lift: Monday August 31st at 4:30 PM

11:30 AM

  • Interviewee: Dr. Marco Valgimigli
  • Topic: Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX (MATRIX Antithrombin)
  • Embargo Lift: Tuesday, September 1st at 5:24 PM

12:00 PM

  • Interviewee: Pr. Thomas MacDonald
  • Topic: The Standard care versus Celecoxib Outcome Trial (SCOT); a randomised, trial comparing the cardiovascular safety of celecoxib versus traditional non-steroidal anti-inflammatory drugs.
  • Embargo Lift: Monday, August 31st at 11:54 AM

12:30 PM

OPEN TIME SLOT

1:00 PM

  • Interviewee: Dr. Gregg Stone
  • Topic: Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
  • Embargo Lift: Sunday, August 30th at 11:54 AM

1:30 PM

  • Interviewee: Dr. Patrick Serruys
  • Topic: Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
  • Embargo Lift: Tuesday, September 1st at 4:48 PM

2:00 PM

  • Interviewee: Dr. Frank Rademakers
  • Topic: Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients
  • Embrago Lift: Sunday, August 30th at 11:18 AM

3:00 PM

  • Interviewee: Dr. Gerasimos Filippatos
  • Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
  • Embargo Lift: Monday, August 31st at 11:18 AM

3:30 PM

  • Interviewee: Dr. Carlos A. Morillo
  • Topic: The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
  • Embargo Lift: Tuesday, September 1st at 12:08 PM

4:00 PM

  • Interviewee: Dr. Stefan James (and guest Dr. Jonas Oldgren)
  • Topic: Wrap-up from a Scandinavian Perspective

4:30 PM

  • Interviewee: Dr. Sergio Leonardi (and guest Pr. Gaetano De Ferrari)
  • Topic: ESC 2015 Wrap-Up in Italian

5:00 PM - 6:00 PM

  • Interviewee: Pr. Gilles Montalescot
  • Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial AND Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study AND ESC 2015 Wrap-up in French
  • Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) and Sunday, August 30th at 5:16 PM (AEGEAN)

Wednesday, September 2, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

  • Interviewee: Pr. Harvey White
  • Topic: ESC 2015 Wrap-Up from Perspective from the Pacific Rim

9:30 AM

  • Interviewee: Pr. Sigmund Silber
  • Topic: ESC 2015 Wrap-Up in German
Retrieved from "https://www.wikidoc.org/index.php?title=ESC_2015_Schedule&oldid=1130653"